Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

illion of H5N1 vaccine sales in the United States, against $192.5 million in the second quarter of 2008. Excluding H5N1 vaccine sales, second-quarter sales were up 18.4%. In the United States, second-quarter net sales were down by 14.5% to euro 402 million, but up 16.2% excluding H5N1 sales.

The second-quarter performance was boosted by strong growth in sales of pediatric combination vaccines. Net sales of Pentacel((R)) (the first 5-in-1 pediatric combination vaccine licensed in the United States in June 2008 against diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b) reached euro 83 million for the quarter.

Net sales of seasonal influenza vaccines rose by 3.3% to euro 32 million.

In May 2009, the U.S. Food and Drug Administration licensed the new sanofi pasteur influenza vaccine manufacturing facility in Swiftwater where production of influenza vaccines has already begun. This facility, representing an investment of $150 million, will produce 100 million doses per year when operating at full capacity. It will take the Group's total production capacity in the United States to 150 million doses of trivalent seasonal influenza vaccine per year.

Sanofi Pasteur received several orders to produce a vaccine against the new A(H1N1) influenza strain, including two contracts from the U.S. Department of Health and Human Services as well as a contract from the French government. Sanofi Pasteur is in discussion with several other governments and announced last June its intent to donate 100 million doses of influenza vaccine to the World Health Organization to help developing countries face the influenza pandemic.

Net sales of Menactra((R)) (quadrivalent meningococcal meningitis vaccine) were up 2.5% at euro 110 million. Filing of Menactra((R)) Infant/Toddler 9 to 12 months in the United States is scheduled for the second half of 200
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... the first time, chemists have succeeded in measuring vibrational ... resolution. The study reveals how vibration of a single ... , The study was performed at the University ... the University of Jyvskyl works as a visiting fellow ... the study. The second team was lead by Professor ...
(Date:8/20/2014)... High performance computing (HPC) will be ... climate and Earth system model to address the ... Eight national laboratories, including Lawrence Livermore , ... Atmospheric Research, four academic institutions and one private-sector ... laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los Alamos, ...
(Date:8/20/2014)... Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: ... presenting at the Baird Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... Wednesday, Sept. 3, 2014. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
(Date:8/20/2014)... Canada (PRWEB) August 20, 2014 Not ... that E&L studies should be performed late in the ... is known. But current regulatory trends suggest that, like ... on the rise. In recent years, multiple drug sponsors ... packages or address specific questions during phase I/II. It’s ...
Breaking Biology Technology:Seeing a molecule breathe 2New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3PAREXEL International To Present At Baird Healthcare Conference 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2
... International ExpansionConference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET)NOVATO, Calif., April 30 , ... Item ... Q1 2008 Comparison, Total BioMarin Revenue ... Total Net Product Revenue $71.9 ...
... Medical, an innovator in 3D ultrasound image-guided adaptive ... Whisenhunt to the position of Vice President of ... Company,s growing global sales team and manage partnerships ... of radiation oncology industry experience to the Company. ...
... 30 Tigris Pharmaceuticals, Inc., a privately held drug ... its novel molecule, AFP-464, during the recent AACR 100th ... a significant advancement in the treatment of Triple Negative ... invasive breast cancer," stated Edmundo Muniz, M.D., Ph.D., President ...
Cached Biology Technology:BioMarin Announces First Quarter 2009 Financial Results 2BioMarin Announces First Quarter 2009 Financial Results 3BioMarin Announces First Quarter 2009 Financial Results 4BioMarin Announces First Quarter 2009 Financial Results 5BioMarin Announces First Quarter 2009 Financial Results 6BioMarin Announces First Quarter 2009 Financial Results 7BioMarin Announces First Quarter 2009 Financial Results 8BioMarin Announces First Quarter 2009 Financial Results 9BioMarin Announces First Quarter 2009 Financial Results 10BioMarin Announces First Quarter 2009 Financial Results 11BioMarin Announces First Quarter 2009 Financial Results 12BioMarin Announces First Quarter 2009 Financial Results 13BioMarin Announces First Quarter 2009 Financial Results 14BioMarin Announces First Quarter 2009 Financial Results 15BioMarin Announces First Quarter 2009 Financial Results 16Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4
(Date:8/20/2014)... fires are visible in in this image of the ... of these were most likely intentionally set in order ... a forest or stand of trees where the land ... deforestation include conversion of forestland to farms, ranches, or ... dark green of the Amazon Rainforest in the middle ...
(Date:8/20/2014)... Ore. -- When are athletes who have suffered concussions ... Oregon study has found that high school athletes who ... 60 days experience a significant regression in their abilities ... The regression, as seen in changes in their balance ... 19 athletes. Ten of the 12 had returned to ...
(Date:8/20/2014)... who are poor experience higher cortisol levels in pregnancy ... the stress hormone, putting them at greater risk ... new research from the University of Colorado Denver. , ... Journal of Human Biology , is the first to ... the socioeconomic status of their mothers during pregnancy. , ...
Breaking Biology News(10 mins):Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3CU Denver researcher shows economic disparities impact infant health 2
... LANSING, Mich. Researchers from Michigan State University,s departments ... create a new wearable sensor network to assess a ... developed by engineering professor Subir Biswas, participants will wear ... arm and lower leg that during any physical ...
... Southwest Foundation for Biomedical Research (SFBR) in San Antonio ... bad cholesterol to accumulate in the blood as a ... strain of laboratory opossums developed at SFBR that has ... when fed a standard low-cholesterol diet, but extremely elevated ...
... Animal flocks, be it honeybees, fish, ants or ... unanimous decisions at a moment,s notice, a phenomenon which ... published today, Wednesday 15 September, in New Journal ... and German Physical Society), uses a particle model to ...
Cached Biology News:Wearable sensor technology to measure physical activity 2Scientists find gene for high cholesterol in blood 2Understanding behavioral patterns: Why bird flocks move in unison 2
... lower consumption of reagents and increased ... Multidrop 384 is an automated dispenser ... dispensing into 384- and 96-well plates.This ... can easily switch from 96- to ...
Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...
... Rotor for use in the ... and Centra-MP4/MP4R. Perfect for ... and other difficult to separate ... containment. Complete with rotor and ...
... The MBS Satellite Thermal Cycler ... flexible solution for medium to ... MBS combines the latest in ... software and PC control, resulting ...
Biology Products: